Meningitis

Meningococcal infection caused by Neisseria meningitidis has the highest incidence rates among individuals aged 16-21. This demographic is particularly vulnerable due to lifestyle factors such as living in close quarters in college dorms.

An initial meningococcal vaccination is recommended for children between the ages of 11-12, which is crucial for building immunity before they enter high-risk environments.
A booster dose should be administered at age 16, ensuring continued protection during college years and early adulthood.

Vaccination is advised for:
- Individuals living in shared accommodations, such as dormitories or military barracks, which increase exposure risk.
- Those traveling to or residing in endemic regions where meningococcal disease is common.
- Individuals with compromised immune systems, particularly those with spleen deficiencies, as their risk for severe infection is heightened.
- If vaccination history is unclear, especially in individuals facing high exposure risks, receiving a vaccine is strongly advised.
Notably, boosters can be safely administered as early as 8 weeks after the initial vaccination if needed.

Patients may present with decreased consciousness, confusion, and disorientation, indicating severe infection progression.
Changes in pupil reaction and eye movements are commonly noted, including photophobia (sensitivity to light) and nystagmus (involuntary eye movement).
Motor responses can vary; patients may initially show normal motor function, but as the disease progresses, hemiparesis (weakness on one side) or hemiplegia (complete paralysis on one side) may develop.
Dysfunction in cranial nerves, especially CN III (oculomotor), IV (trochlear), VI (abducens), VII (facial), and VIII (vestibulocochlear) can lead to significant cognitive and physical impairment.
Other symptoms may include severe headaches, muscle aches (myalgia), and changes in personality or memory.
Common systemic signs include nausea, vomiting, fever, chills, tachycardia, and a distinctive red macular rash that is a hallmark of meningococcal meningitis.

Maintaining adequate airway, breathing, and circulation is crucial, along with regular monitoring of vital signs and neurological status every 2-4 hours.
Performing cranial nerve assessments to check for dysfunction of CN III, IV, VI, VII, and VIII.
Pain management is essential; various therapies including pharmacologic and non-pharmacologic methods should be employed.
Documenting intake/output accurately and monitoring body weight is critical to assess fluid retention and overall fluid balance.
Minimize environmental stimuli to create a calming atmosphere, and maintain the patient's head elevated at 30 degrees to reduce ICP.
Implement strict Transmission-Based Precautions for patients with bacterial meningitis to prevent spreading the infection.

Carefully monitor for potential complications such as:
- Increased intracranial pressure (ICP), which may lead to further neurological deterioration.
- Vascular dysfunction that can cause additional ischemic damage.
- Fluid and electrolyte imbalances, which can complicate the clinical picture.
- Seizures and shock, both of which require immediate medical intervention.

Document neurological status thoroughly every 4 hours, noting any changes.
Early signs of increased ICP must be observed closely, particularly decreased LOC.
Management of seizure risk is vital, using both preventive medications and monitoring strategies.
Initiate broad-spectrum antibiotics immediately after diagnosis, before culture and Gram stain results are returned, to improve patient outcomes. Treatment typically involves a 2-week course of intravenous (IV) antibiotics, which should be monitored for efficacy and possible adverse reactions.
Preventive measures for those who have been in close contact with infected individuals should be taken seriously, including drugs such as rifampin, ciprofloxacin, or ceftriaxone to prevent disease spread.

The primary target of infection in meningitis is the meninges, specifically the pia mater and the arachnoid layer.
Various pathogens such as bacteria, viruses, fungi, and protozoa can cause meningitis, each presenting different clinical manifestations and severities.
Common routes of entry include the bloodstream, penetrating trauma (such as wounds), surgical interventions, or rupture of abscesses.
Basilar skull fractures increase risk for CSF leakage, which can lead to subsequent contamination and infection.
Symptoms of meningitis can vary significantly depending on the causative organism. Bacterial meningitis tends to be more severe and often results in higher mortality rates; common types include pneumococcal and meningococcal.
Increased ICP can occur due to blockage of CSF circulation, which profoundly affects cerebral blood flow and overall brain function.

Key diagnostic tests include:
- CSF analysis, which evaluates cell count, glucose levels, and culture sensitivity to identify the causative organism.
- CT scans may be required for older or immunocompromised patients prior to lumbar puncture to assess potential intracranial lesions.
- Blood cultures and complete blood counts (CBCs) assist in evaluating the severity of infection and maintaining electrolyte balance.
- X-rays and imaging modalities can also be employed to identify infection sources or monitor complications.

Vaccinations are a primary preventive strategy against meningitis and include:
- Haemophilus influenzae type B (Hib), pneumococcal, mumps, varicella, and meningococcal vaccines.
Mandatory vaccination programs in educational and community settings have significantly decreased the incidence of meningitis, especially in environments where individuals are in close contact with one another, such as schools and military barracks.